Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Company Information
About this company
Key people
Veli - Matti Mattila
Independent Chairman for the Board
Outi Vaarala
Senior Vice President, Research and Development and Innovative Medicines, Member of the Executive Management Board
Mikko Kemppainen
General Counsel, Member of the Executive Management Board, Company Secretary
Jani Korhonen
Employee Representative on the Executive Management Board
Kari Jussi Aho
Independent Director
Maziar Mike Doustdar
Independent Director
Ari Lehtoranta
Independent Director
Liisa Hurme
President, Chief Executive Officer, Member of the Executive Management Board
Hilpi Rautelin
Independent Vice Chairman of the Board
Rene Lindell
Chief Financial Officer, Member of the Executive Management Board
Julia Irene Macharey
Senior Vice President, People and Culture, Member of the Executive Management Board
Satu Ahomaeki
Senior Vice President, Generics and Consumer Health, Member of the Executive Management Board
Juhani Kankaanpaeae
Senior Vice President, Global Operations, Fermion, Member of the Executive Management Board
Niclas Lindstedt
Senior Vice President, Animal Health, Member of the Executive Management Board
Hao Pan
Senior Vice President, Branded Products, Member of the Executive Management Board
Click to see more
Key facts
- Shares in issue109.61m
- EPICORNBV
- ISINFI0009014377
- LocationFinland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€9.96bn
- Employees4,029
- ExchangeHelsinki Stock Exchange
- IndexFinland-OMX-Helsinki-All-Share
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.